An open, multicenter flexible dose escalation study to evaluate the efficacy and safety of sildenafil administered as required to male patients with erectile dysfunction
Journal Title: Progress in Health Sciences - Year 2012, Vol 2, Issue 2
Abstract
Objective: To evaluate the efficacy, satisfaction, safety and tolerability of sildenafil taken as prescribed prior to anticipated sexual activity in male outpatients with erectile dysfunction (ED). Materials and methods: Two hundred and three adult male with ED participated in a 2-week, no treatment, run-in period followed by a 6-week open treatment period. In the present trial, they received 50 mg of Viagra. The primary efficacy variable was the change from baseline in response to item 3 and 4 of the International Index of Erectile Function (IIEF). The secondary efficacy variables were as follows: response to the other questions of the IIEF, the IIEF domain scores, response to the Global Efficacy Assessment Question (GAQ), the Event Logs of Erectile Function and Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire. Results: A total of 203 subjects were screened and 175 subjects received the study drug. A total of 168 subjects completed the study. The percent of improved erection based on the (GAQ) was 84.5%. The mean rate of successful intercourse was 0.6. Almost thirty-seven percent of patients were satisfied with the effect of treatment in their erections at week 2. The treatment satisfaction increased to 83.3 % at the end of the study, after 62.6 % of patients increased dose to 100 mg of Viagra. A total of 7 (4%) subject discontinued the study prior to the final visit. The reasons of discontinuation were: adverse events - 1.1%, lost to follow-up - 1.1%, subject no longer willing to participate - 3. Of the 175 subjects who received Viagra, 34 subjects experienced at least one adverse event. Conclusions: The results of the analyses of the responses to the primary variable were highly statistically significantly in favour of sildenafil, as well as the results of the analyses of all the secondary efficacy variables. These findings support effectiveness of sildenafil. The adverse event profile of sildenafil in this study was consistent with the labeled adverse events for this product.
Authors and Affiliations
B. Darewicz, T. Werel, M. Chlabicz, J. Kudelski, Skrodzka
Keywords
Related Articles
- EP ID EP100684
- DOI -
- Views 81
- Downloads 0
Analysis of fungal air pollution using different samplers
Purpose: The aim of this study was the analysis of fungal air pollution in different rooms using different the air samplers. Material and methods: Air for mycological studies was collected from various hospital rooms....
Michael Faraday (1791 – 1867), science, medicine, literature and his disability
Numerous studies on Michael Faraday were published, but this article will shed some light on Faraday's diseases and disability, and on some of his scientific and medical achievements.
Cardio-respiratory status of stone grinders and brick field workers from west Bengal, India
Introduction: Quartz crushing and brick making industry are informal and demands heavy manual labour. They are socio-economically backward and are unable to avail of social security’s scheme meant for protection of the h...
The frequency of chronic diseases and a health-promoting lifestyle in a group of elderly Romani people living in Northern Turkey
Purpose: To analyse the frequency of chronic diseases among Romani people who are sixty and older as well as their health-promoting lifestyle. Materials and methods: This research was conducted as a descriptive study be...
Neurologic adverse events following vaccination
The present review summarizes data on neurological adverse events following vaccination in the relation to intensity, time of onset, taking into account the immunological and non-immunological mechanisms. The authors des...